Valencia-Luis Oliag

Research site

Spain Calle De Luis Oliag Nº 62, 46006 Valencia, Spain

1 trial recruiting
Respiratory syncytial virus infection · Influenza immunisation · Pneumonia respiratory syncytial viral
Adult patients

About Specializations

Valencia-Luis Oliag in Valencia, Spain specialises in clinical trials of conditions such as Respiratory syncytial virus infection, Influenza immunisation, Pneumonia respiratory syncytial viral, Respiratory syncytial virus bronchiolitis, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases

The Valencia‑Luis Oliag site is conducting research aimed at protecting older adults from serious respiratory tract diseases through vaccination strategies.

Evaluation of the humoral immune response after a single revaccination dose of an RSV vaccine
Demonstration of non‑inferior antibody levels with a high‑dose influenza vaccine in seniors
Assessment of RSV vaccine effectiveness in reducing hospitalisations for respiratory disease

These studies help the community in Valencia understand how to better prevent influenza and RSV‑related complications in people aged 60 and above at the Valencia‑Luis Oliag facility.

Virus Diseases

Research at this hospital focuses on combating viral infections that cause seasonal illness, with a special emphasis on influenza and respiratory syncytial virus.

Immune response measurement after administration of the RSVPreF3 (Arexvy®) vaccine
Safety and immunogenicity testing of a trivalent high‑dose influenza vaccine in adults over 60
Real‑world evaluation of RSV vaccine impact on severe respiratory outcomes

By enrolling participants from the Valencian Community, the site contributes valuable data on how viral vaccines can improve health outcomes for older populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Calle De Luis Oliag Nº 6246006 ValenciaSpain

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 5

More sites in Valencia Spain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

3 clinical trials

Respiratory syncytial virus infection

Recruiting

Effectiveness of respiratory syncytial virus glycoprotein F (pre‑fusion) vaccine adjuvanted with AS01E in preventing RSV‑related respiratory disease hospitalization in adults ≥60 years

Registered drugNo placebo

Effectiveness of respiratory syncytial virus glycoprotein F (pre‑fusion) vaccine adjuvanted with AS01E in preventing RSV‑related respiratory disease hospitalization in adults ≥60 years

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
Sponsor:Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana

Contact Research Centre

Respiratory syncytial virus infection+3

Not recruiting

Study on the Immune Response and Safety of RSVPreF3 OA Vaccine in Adults Aged 60+ with Respiratory Syncytial Virus Infections

Registered drugNo placebo

Study on the Immune Response and Safety of RSVPreF3 OA Vaccine in Adults Aged 60+ with Respiratory Syncytial Virus Infections

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Influenza immunisation

Not recruiting

Study on the Safety and Immune Response of a High-Dose Influenza Vaccine in Adults Aged 60 and Over, Comparing Trivalent Influenza Vaccine with a Drug Combination

Registered drugNo placebo

Study on the Safety and Immune Response of a High-Dose Influenza Vaccine in Adults Aged 60 and Over, Comparing Trivalent Influenza Vaccine with a Drug Combination

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:A/Victoria/4897/2022 (H1N1)Pdm09-Like Strain (A/Victoria/4897/2022, Ivr-238)
Sponsor:Abbott Biologicals B.V.

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites